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OBJECTIVE — To examine the relationship of parity with diabetes and markers of glucose
homeostasis in older women.
RESEARCHDESIGNANDMETHODS — Weuseddatafromthefemaleparticipantsin
the Cardiovascular Health Study, a longitudinal cohort of adults aged 65 years. These data
included an assessment of parity (baseline) and fasting serum levels of glucose, insulin, and
medication use (baseline and follow-up). We estimated both the cross-sectional relationship of
parity with baseline diabetes and the relationship of parity with incident diabetes.
RESULTS — In unadjusted analyses, women with grand multiparity (5 live births) had a
higher prevalence of diabetes at baseline compared with those with fewer births and with
nulliparouswomen(25vs.12vs.15%;P0.001).Inregressionmodelscontrollingforageand
race, grand multiparity was associated with increased prevalence of diabetes (prevalence ratio
1.57 [95% CI 1.20–2.06]); with addition of demographic and clinical factors to the model, the
association was attenuated (1.33 [1.00–1.77]). In ﬁnal models that included body anthropo-
metrics, the association was no longer signiﬁcant (1.21 [0.86–1.49]). In those without diabetes
at baseline, parity was not associated with incident diabetes or with fasting glucose; however,
there was a modest association of parity with fasting insulin and homeostasis assessment model
of insulin resistance.
CONCLUSIONS — Grandmultiparityisassociatedwithdiabetesinelderlywomenincross-
sectional analyses. This relationship seems to be confounded and/or mediated by variation in
bodyweightandsociodemographicfactorsbyparitystatus.Inoldernondiabeticwomen,higher
parity does not pose an ongoing risk of developing diabetes.
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P
regnancy is a time-limited condi-
tion;however,thereisevidencethat
child-bearing could have a long-
term impact on the health of women. The
dramatic alterations in physiology and
metabolism associated with the state of
pregnancy have sparked questions about
the association of child-bearing with the
subsequent risk of conditions such as
diabetes.
Pregnancy induces a state of insulin
resistance in a woman’s peripheral tis-
sues. In susceptible nondiabetic women,
insulin resistance may be severe enough
to cause gestational diabetes mellitus. It is
generally assumed that pregnancy-
associatedinsulinresistanceresolvesafter
parturition, but subtle metabolic changes
couldpersist,leadingtoincreasedriskfor
diabetes in the future.
Researchers examining the relation-
ship between parity and risk of diabetes
have come to discordant conclusions.
Some studies have suggested a link be-
tween higher parity and increased risk
of future diabetes (1–5). However,
other studies have demonstrated no in-
creased risk of diabetes associated with
child-bearing (1,6). In the face of con-
ﬂictingdata,someresearchershavesug-
gested that the relationship of increased
parity with higher diabetes risk that is
observed in some studies is confounded
or mediated by other factors, such as
body weight and socioeconomic status
(6).
Theaimofourstudywastoexamine
the relationship between parity and di-
abetes in older women, who have the
highest prevalence of diabetes. We hy-
pothesized that higher parity was posi-
tively associated with the prevalence of
diabetes in older women. We studied the
inﬂuence of potential confounding vari-
ables,suchaseducation,race,andalcohol
intake, on our hypothesized association
between parity and diabetes as well as
possible mediators of the association,
such as BMI and waist circumference. Fi-
nally, we tested the inﬂuence of parity on
biochemical markers of glucose ho-
meostasis, such as fasting serum glucose
and insulin levels, and the homeostasis
model assessment of insulin resistance
(HOMA-IR) in those without diabetes.
RESEARCH DESIGN AND
METHODS— The Cardiovascular
Health Study (CHS) is a National Insti-
tutes of Health National Heart, Lung, and
Blood Institute–funded, population-
based longitudinal study of adults aged
65years(7).(AfulllistofprincipalCHS
investigators and institutions can be
found at http://www.chs-nhlbi.org/pi.
htm.)Themainobjectiveofthestudywas
to study the onset and course of coronary
heart disease and stroke. Participants
were sampled from Medicare eligibility
lists in four U.S. communities: Forsyth
County, North Carolina; Sacramento
County, California; Washington County,
Maryland; and Pittsburgh, Pennsylvania.
CHS initially recruited 5,201 men and
women in 1989–1990. Subsequently,
an additional 687 black women were
recruited in 1992–1993. Participants
underwent extensive physical and labo-
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biannual in-person or telephone contacts
were used to ascertain and verify the
incidence of outcome events. For our
analysis,onlyfemaleparticipantswerein-
cluded (n  3,393). We excluded 78
women with missing information on par-
ity, 59 with missing information on base-
line diabetes status, and 45 with missing
information on other covariates, leaving a
ﬁnal eligible sample of 3,211 women.
Parity
Our main exposure of interest was parity,
assessed in women at the baseline inter-
view, with the question, “How many live
births have you had?” The response was
modeled as a categorical variable: nullip-
arous (0 births), 1–2 livebirths, 3–4 live-
births, and grand multiparity (5
livebirths).
Diabetes
Informationonmedicationusewasascer-
tained annually with detailed medication
inventories (8). Fasting serum blood glu-
cose and insulin were measured at the
Central Laboratory at the University of
Vermont in 1989–1990, 1992–1993,
and 1996–1997 (9).
In this cohort of older women, we
studied both the cross-sectional relation-
ship between parity and prevalent diabe-
tes at baseline and the association of
parity with incident diabetes only among
those who were nondiabetic at baseline
(n  2,761). Baseline diabetes was as-
sessed using data from the baseline clinic
examination and deﬁned with American
Diabetes Association criteria as the use of
hypoglycemic medications or a fasting
blood glucose of 126 mg/dl. Incident
diabetes was deﬁned as the ﬁrst use of
diabetes medications or by a criterion of
fasting blood glucose of 126 mg/dl dur-
ing the follow-up years for which fasting
blood glucose was available. Participants
were followed for incident diabetes out-
come through 2007. Insulin resistance
was estimated at baseline using HOMA-
IR, calculated by the following formula:
HOMA-IR  fasting serum insulin (mi-
crounits per milliliter)  fasting plasma
glucose (millimoles per liter)/22.5.
Statistical analysis
We used descriptive statistics to charac-
terize participant’s demographic charac-
teristics at baseline. To examine the
relationshipbetweenparityandprevalent
diabetes, we estimated the prevalence ra-
tios using generalized linear models with
a log-link and Poisson distribution (10).
Modelsusingabinomiallinkyieldedsim-
ilar point estimates and conﬁdence inter-
vals but did not converge in all cases. To
examine the association between parity
andincidentdiabetesinthosewithoutdi-
abetes at baseline, we used Cox propor-
tional hazard models to estimate hazard
risk ratios related to parity.
For both the incident and prevalent
diabetes outcomes, we examined the re-
lationshipbetweenparityandoutcomes
in multivariable sequentially adjusted
models. Initial multivariable models
controlled for age and race. The next
models controlled for several possible
confounders including age, race, in-
come (three categories), education
(more than high school, high school, or
less than high school), marital status
(married, single, widowed, or divorced),
height (centimeters) smoking (current,
never, or former), study site, and alco-
hol intake (user/abstainer). Our ﬁnal
models contained all of the previously
listed potential confounders and in ad-
dition controlled for body anthropo-
metrics as potential mediators (baseline
BMI [calculated from measured weight
and height], height and measured waist
circumference, and self-report of BMI at
age 50 years; because of missing data,
age50yearsBMIwasimputedfromage,
race, and baseline BMI in 128 women).
In these ﬁnal models, we examined the
degree of mediation using the SAS me-
diate macro (11).
We also conducted multivariable lin-
ear regression analyses to examine
whether parity was associated with base-
line fasting serum glucose, insulin levels,
and HOMA-IR only among those without
diabetes at baseline. Because insulin and
HOMA-IR were, as expected, right-
skewed, both were log-transformed to
improve normality.
AllanalyseswereconductedwithSAS
statistical software (version 9.2).
RESULTS— Baselinecharacteristicsof
our sample are presented in Table 1. The
baselineageofoursamplewas72.5years.
Those with grand multiparity (5 live-
births) were more likely to be black, have
larger BMI and waist circumferences at
baseline,morelikelytoabstainfromalco-
hol,andlesslikelytohavegraduatedfrom
high school. In unadjusted analyses, dia-
betes was considerably more prevalent in
women with grand multiparity (25%)
compared with those with fewer live-
births (12%) and with those who were
nulliparous (15%; P  0.001).
Table 1—Baseline characteristics of women enrolled in CHS
Total Nulliparous
1–2 live
births
3–4 live
births
5 live
births
3,211 568 1,444 887 312
Age (years) 72.5  5.4 73.7  5.9 72.9  5.5 71.2  4.7 71.8  5.3
Black race 500 (15.6) 118 (20.8) 197 (13.6) 97 (10.9) 88 (28.2)
Less than high school education 921 (28.7) 161 (28.4) 383 (26.5) 222 (25.0) 155 (49.7)
Current smoking 404 (12.6) 73 (12.9) 184 (12.7) 112 (12.6) 35 (11.2)
Alcohol abstainer 1,791 (55.8) 317 (55.8) 788 (54.6) 464 (52.3) 222 (71.2)
BMI (kg/m
2) 26.8  5.3 26.6  5.4 26.4  5.2 27.0  5.2 28.5  5.5
Waist circumference (cm) 92.0  14.4 92.0  14.7 90.9  14.2 92.3  13.7 96.8  15.5
Height (cm) 158.8  6.2 158.4  6.7 158.5  6.2 159.5  5.9 159.1  6.4
BMI age 50 years (kg/m
2) 25.3  3.0 25.3  3.1 25.1  3.0 25.2  3.0 26.2  3.1
C-reactive protein (mg/l) 4.8  7.6 5.0  8.0 4.7  7.0 4.7  8.5 5.1  6.9
Diabetes 450 (14.0) 86 (15.1) 175 (12.1) 111 (12.5) 78 (25.0)
Data are means  SD or n (%).
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In regression models controlling for age
and race, we observed a nearly 60% in-
crease in prevalent diabetes associated
with grand multiparity compared with
women who were nulliparous (Table 2).
Lesser degrees of parity were not associ-
ated with prevalent diabetes. After addi-
tion of demographic and clinical factors
(including measures of socioeconomic
status) to the model, the observed in-
crease in prevalent diabetes associated
with grand multiparity was reduced to
33%butremainedstatisticallysigniﬁcant.
In a ﬁnal model that controlled for body
anthropometrics,theprevalenceofdiabe-
tes associated with grand multiparity was
21% higher than that for the referent nul-
liparous group and no longer signiﬁcant.
The degree of attenuation was somewhat
less if we adjusted only for BMI recalled
from age 50 years rather than measured
BMI also (prevalence ratio 1.27 [95% CI,
0.96–1.68]),consistentwithagreaterde-
gree of measurement error in recalled
BMI. Comparing generalized estimating
equationmodelswithandwithoutadjust-
ment for anthropometrics, these factors
explained 44% ([2–86%]; P  0.04) of
the adjusted association of grand multi-
parity with prevalent diabetes.
We observed similar associations be-
tween parity and prevalent diabetes in
blacksandwhites(Table2).Althoughthe
association of grand multiparity with
prevalentdiabeteswasnumericallystron-
ger in blacks, interaction terms of race
with grand multiparity were not signiﬁ-
cant, even in models that included an-
thropometrics (P  0.16).
Parity and incident diabetes
We next examined the relationship of
parity with incident diabetes. Despite the
strong association of grand multiparity
with diabetes at baseline, it was not asso-
ciated with the incident development of
diabetes in older women (Table 3).
Parity and metabolic markers
Unadjusted analysis suggested a modest
trend toward increased fasting insulin
andHOMA-IRassociatedwithgrandmul-
tiparity, whereas fasting glucose was not
signiﬁcantly associated with parity (Table
4). In multivariable models, controlling
for age, race, marital status, income, edu-
cation,height,alcoholuse,clinicsite,and
smoking, we again observed no associa-
tion with fasting glucose but a trend to-
ward increased insulin and HOMA-IR
with higher categories of parity (Ptrend 
0.01 for insulin and 0.02 for HOMA-IR).
In analyses stratiﬁed by race, there
was no interaction between parity and
race and fasting glucose (P  0.3). Inter-
mediate degrees of parity appeared to
have a greater impact on insulin and
HOMA-IR in black women than in white
women, whereas the reverse was true for
grandmultiparity (Table 4). Interaction
termsofparity(deﬁnedcategorically)and
racewerestatisticallysigniﬁcantinthead-
justed models with log(insulin) and log-
(HOMA-IR) as the outcome (P  0.02 for
both). When we tested the interaction
speciﬁcally between race and grandmul-
tiparity, the P values for effect modiﬁca-
tion by race were 0.90, 0.06, and 0.09 for
glucose,log(insulin),andlog(HOMA-IR),
respectively. The apparent differences by
race in the relationship of parity with in-
sulin resistance were not markedly differ-
ent in analyses that further adjusted for
anthropometrics (data not shown).
CONCLUSIONS — Our study,
among the ﬁrst in a population-based co-
hort of older women, helps to elucidate
the relationship of parity with diabetes
among older women. We found that
grand multiparity (5 live births) was as-
sociated with higher risk of prevalent di-
abetes in analyses controlling for age and
race. This association was attenuated but
continued to be statistically signiﬁcant
after adjustment for demographic and
clinical factors. When anthropometric
measures were added to the models, the
magnitude of association was further at-
tenuatedandbecamestatisticallyinsignif-
icant. Thus, the association of grand
multiparity with increased prevalence of
diabetes seems to be confounded or me-
diated,inlargepart,byvariationinsocio-
demographic factors and higher body
weight associated with grand multiparity.
Lesser degrees of parity were not associ-
ated with prevalence of diabetes in older
women. Further, we did not observe any
signiﬁcant variation in the association of
Table 2—Multivariable models of parity and prevalent diabetes
Model 1:
age and race
Model 2:
potential
confounders*
Model 3: all potential
confounders and
anthropometrics†
All
Nulliparous 1.0 1.0 1.0
1–2 live births 0.85 (0.67–1.08) 0.85 (0.66–1.09) 0.87 (0.65–1.06)
3–4 live births 0.91 (0.70–1.19) 0.90 (0.68–1.18) 0.88 (0.63–1.08)
5 live births 1.57 (1.20–2.06) 1.33 (1.00–1.77) 1.21 (0.86–1.49)
Blacks
Nulliparous 1.0 1.0 1.0
1–2 live births 0.78 (0.51–1.18) 0.81 (0.54–1.23) 0.86 (0.58–1.29)
3–4 live births 0.93 (0.58–1.49) 0.91 (0.56–1.50) 1.02 (0.64–1.64)
5 live births 1.64 (1.10–2.45) 1.54 (1.02–2.32) 1.43 (0.98–2.10)
Whites
Nulliparous 1.0 1.0 1.0
1–2 live births 0.88 (0.66–1.18) 0.86 (0.62–1.19) 0.88 (0.64–1.20)
3–4 live births 0.92 (0.67–1.26) 0.89 (0.63–1.26) 0.84 (0.60–1.18)
5 live births 1.50 (1.03–2.17) 1.20 (0.81–1.78) 1.06 (0.72–1.57)
Data are prevalence ratio (95% CI). Generalized linear models with a log-link and Poisson distribution are
shown. *Model 2: age, race, marital status (4), income (3), education (3), height (in centimeters), alcohol
yes/no, clinic (4), and smoking (3). †Model 3: also for BMI, BMI at age 50 years, and waist circumference.
Table 3—Multivariable models of parity and incident diabetes
Incident
diabetes
Model 1:
age and race
Model 2: potential
confounders*
Nulliparous 33 1.0 1.0
1–2 live births 99 1.09 (0.73–1.62) 0.96 (0.63–1.47)
3–4 live births 60 0.95 (0.62–1.46) 0.86 (0.54–1.35)
5 live births 23 1.23 (0.72–2.10) 0.95 (0.54–1.67)
Data are n or HRs (95% CI). Cox proportional hazard models were used. *Model 2: age, race, marital status
(4), income (3), education (3), height (in centimeters), alcohol yes/no, clinic (4), and smoking (3).
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whites.
On the other hand, among women
who remained free of diabetes into older
age, parity was not associated with inci-
dent diabetes nor with fasting glucose
among those free of diabetes. However,
there was a statistically signiﬁcant, albeit
weak in magnitude, association of parity
andfastinginsulinandHOMA-IRatbase-
line in women free of diabetes. Our data
are generally consistent with the hypoth-
esisthatparityappearstoplayanongoing
role in the development of diabetes
through middle age, but its effect wanes
among older women who have remained
nondiabetic.
Previous studies examining the rela-
tionshipbetweenparityanddiabeteshave
come to discordant conclusions. Some
havefoundthatparity,particularlyhigher
levels of parity, is associated with in-
creased risk of diabetes. For example, Ni-
cholson et al. (5) analyzed a cohort of
middle-aged black and white women and
found that those who had borne 5 chil-
dren had twice the risk of incident diabe-
tes in unadjusted analyses (hazard ratio
[HR] 2.10 [95% CI 1.73–2.53]). In their
study, the increased risk of diabetes was
attenuated but persisted after adjustment
for factors including sociodemographic
factors and anthropometrics (adjusted
HR 1.27 [1.02–1.57]). Consistent with
our ﬁndings, an earlier study examining
the relationship between parity and glu-
cose homeostasis in middle-aged to older
women found that after adjustment for
covariates,eachpregnancywasassociated
with increased fasting insulin and de-
creasedinsulinsensitivitythatwasnotex-
plained by obesity and body composition
measures (12). This study suggested that
changes in insulin sensitivity related to
parity persist many years after child-
bearing.
However, other studies have not
shown similar effects. For example, Man-
son et al. (6) examined a cohort of
120,000 registered nurses, aged 30–55
years at baseline. Similar to our ﬁndings,
their unadjusted analyses suggested that
women with high parity (deﬁned in their
study as 6 live births) had a 50% higher
risk of incident diabetes over 12 years of
follow-up. However, after adjustment for
age and BMI, they observed no signiﬁcant
relationship between parity and incident
diabetes. Their results are concordant
withoursinconnectinghighlevelsofpar-
ity with diabetes in middle age and in the
ﬁnding that the effects of high parity are
largely related to the impact on midlife
weight. Together, ours and the previous
study emphasize the importance of
weight management targeted to multipa-
rous women.
Our study has several strengths, in-
cludinganalysisofalargebiracialsample.
We also had standardized measures of
several potential confounding and medi-
ating variables, including directly mea-
sured weight and waist circumference,
allowing us to examine the mechanism of
association of our relationship of interest.
However, there are several limitations to
be considered. First, some information
that may have been helpful in the inter-
pretation of the results, such as history of
gestational diabetes mellitus, was not
available. Next, our results may not be
generalizable to other races and ethnici-
ties, such as Native Americans and Asians
(13,14), and we may have had limited
power to detect differences between
blacks and whites. In addition, we had a
limited number of cases of incident dia-
betes, particularly among grand multipa-
rous women, 25% of whom already had
diabetesatbaseline,limitingourpowerto
detect a small effect of grand multiparity
on incident diabetes. Finally, because our
analysis examines the relationship be-
tween a relatively early life exposure with
outcomes much later in life, our results
may be inﬂuenced by survivor bias. Ac-
cordingly, selective survival of women
into older age may result in an attenuated
measured association of parity with later
diabetes outcomes.
In summary, grand multiparity, but
not lesser degrees of parity, is associated
withprevalentdiabetesinelderlywomen.
Muchofthehigherprevalenceofdiabetes
associated with past child-bearing seems
to be mediated (or confounded) by the
heavier BMI associated with grand multi-
parity. This ﬁnding presents an opportu-
nity for education and intervention
related to weight control among grand
multiparous women to reduce diabetes
prevalence. In nondiabetic women who
have reached older age, higher parity is
not associated with increased risk of de-
veloping diabetes but tended to be asso-
ciated with small increases in fasting
insulin and HOMA-IR. Additional longi-
tudinal studies designed speciﬁcally to
Table 4—Parity and metabolic markers among those without diabetes
Unadjusted baseline measures of metabolic markers by parity
Fasting glucose
(mg/dl)
Log(fasting insulin)
(mU/l) Log(HOMA-IR)
Nulliparous 98.9  10.1 2.5  0.4 1.1  0.5
1–2 live births 98.4  9.9 2.5  0.5 1.1  0.5
3–4 live births 98.5  9.4 2.5  0.5 1.1  0.5
5 live births 99.4  10.7 2.6  0.5 1.2  0.5
Multivariable models of metabolic markers by parity and race*
Fasting glucose Fasting insulin HOMA-IR
All races
Nulliparous Referent Referent Referent
1–2 live births 0.6 (0.6) 0.01 (0.03) 0.00 (0.03)
3–4 live births 0.3 (0.6) 0.05 (0.03) 0.04 (0.03)
5 live births 0.2 (0.8) 0.06 (0.04) 0.07 (0.04)
Blacks
Nulliparous Referent Referent Referent
1–2 live births 1.7 (1.5) 0.15 (0.07) 0.17 (0.08)
3–4 live births 0.2 (1.8) 0.10 (0.09) 0.10 (0.10)
5 live births 1.3 (2.1) 0.03 (0.10) 0.04 (0.11)
Whites
Nulliparous Referent Referent Referent
1–2 live births 1.0 (0.6) 0.02 (0.03) 0.03 (0.03)
3–4 live births 0.5 (0.7) 0.03 (0.03) 0.02 (0.03)
5 live births 0.1 (0.9) 0.07 (0.04) 0.07 (0.05)
Data are means  SD or  coefﬁcient (SEM). *Multivariable linear regression: models include age, race,
marital status (4), income (3), education (3), height (in centimeters), alcohol yes/no, clinic (4), and smoking
(3).
Fowler-Brown and Associates
care.diabetesjournals.org DIABETES CARE, VOLUME 33, NUMBER 8, AUGUST 2010 1781study the long-term medical effects of
child-bearing should be conducted. Fu-
ture studies should include multiple lon-
gitudinal measures of diabetes related
factors over time to better understand the
interplay of risk factors over time.
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